Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts
阿达木单抗生物类似药SB5在炎症性肠病中的有效性和安全性：从原研药转换为SB5、双重生物类似药转换以及未接受过生物类似药治疗的SB5观察性队列的研究结果
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjab100
Derikx, Lauranne A A P; Dolby, Heather W; Plevris, Nikolas; Lucaciu, Laura; Rees, Caitlin S; Lyons, Mathew; Siakavellas, Spyros I; Constantine-Cooke, Nathan; Jenkinson, Philip; Su, Shanna; O'Hare, Claire; Kirckpatrick, Laura; Merchant, Lynne M; Noble, Colin; Arnott, Ian D; Jones, Gareth-Rhys; Lees, Charlie W
